Canadian Healthcare Technology Logo
  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us

GE Vscan [1400×150]

GE Vscan [1400x150]

Enovacom SickKids case study

Enovacom SickKids case study

Imaging News

Densitas’s AI-powered software to be used in Germany

September 18, 2019


Mo AbdolellHALIFAX – Densitas Inc., a leading provider of AI solutions for digital mammography, announced that it has won a procurement of its densitas densityai software for deployment in up to 24 breast cancer screening clinics across Germany that will provide breast density measurements at point of care to identify women for supplemental breast cancer screening as part of the DIMASOS 2 Trial.

Prof. Dr. Sylvia H. Heywang-Köbrunner, head of Referenzzentrum Mammographie München, internationally recognized for her pioneering work in contrast-enhanced breast MRI and modern biopsy procedures, is using densitas densityai breast density measures to establish a supplemental ultrasound screening protocol in the DIMASOS 2 trial.

“Women with dense breasts are subject to the masking effect of mammographic density and its association with breast cancer risk. The objective of the DIMASOS 2 trial is to test whether combined mammography/ultrasound exams can improve early cancer detection and if this can feasibly and cost effectively be done in routine screening workflow,” said Dr. Heywang-Köbrunner.

“The unique ability of the Densitas software to analyze prior ‘for presentation’ mammograms from a wide range of mammography scanner vendor models is pivotal to this trial and is important for any practical clinical deployment.”

Densitas densityai delivers fully automated, standardized, and reproducible breast density assessments from standard DICOM clinical use mammograms. Results from densitas densityai are generated by two distinct algorithms that decouple the breast density assessment into quantitative and qualitative scales in alignment with the ACR BI-RADS 4th and 5th edition density classification systems.

These results can be incorporated into breast cancer risk models to provide standardized and reproducible patient-specific risk estimates.

“Being selected as the vendor of choice to provide automated breast density assessment for the DIMASOS 2 Trial attests to our modern AI-driven technology superseding dated breast density algorithms developed prior to the introduction of the ACR BI-RADS 5th ed. density scale in 2013,” said Mo Abdolell (pictured), Densitas CEO.

“Densitas densityai processes the same clinical use images that radiologists examine, setting it apart by enabling seamless PACS-centric integrations and retrospective auditing capabilities of routinely archived exams. This makes it an ideal fit for the DIMASOS 2 trial.

He added, “More broadly this also simplifies clinical deployments, and is more cost effective and deeply integrated into radiologist reporting workflows with key applications and platforms that include Nuance PowerScribe One and PowerScribe 360 Reporting, The Nuance AI Marketplace, Ikonopedia structured breast reporting and tracking software, TeraRecon’s AI interoperability platform, EnvoyAI, Blackford Platform and Curated Marketplace, and Three Palm Software’s WorkstationOne.”

About Densitas
Our vision is to move the needle in breast cancer screening through tailored patient management for sustainable healthcare service delivery. Densitas develops advanced AI-powered solutions that deliver on-demand actionable insights through point-of-care and advanced healthcare analytics for breast health management aimed at improved patient outcomes. The densitasai™ platform, comprising densitas densityai™, densitas qualityai™ and densitas riskai™ tackles pressing challenges facing breast cancer screening today, including precision breast health, mammography quality, workflow efficiencies, compliance with national standards, and meeting accreditation requirements. For more information, please visit www.densitas.health.

PreviousNext

VG2022

VG2022

News and Trends

  • COVID-19 had a big impact on data management
  • GE to accelerate commercialization of AI innovations
  • Unique homecare EMR designed by clinicians for clinicians
  • London hospitals offer virtual-visits designed for inclusiveness
  • How technology can be deployed to assist the aged and their families
More from the Print Edition

Subscribe

Subscribe

Free of charge to Canadian hospital managers and executives in nursing homes and home-care organizations. Learn More

Follow us on Social Media!

Follow us on Social Media!

Infoway [May2022]

Infoway [May2022]

eHealth 2022

eHealth 2022

MEDICA 2022

MEDICA 2022

Advertise with us

Advertise with us

Calian-Fraser Health

Calian-Fraser Health

Sectra best in KLAS

Sectra best in KLAS

Zebra [May2022]

Zebra [May2022]

Cdn Institute HCI West

Cdn Institute HCI West

Talkdesk

Talkdesk

VG2022

VG2022

VG2022

VG2022

Advertise with us

Advertise with us

Calian-Fraser Health

Calian-Fraser Health

Sectra best in KLAS

Sectra best in KLAS

Zebra [May2022]

Zebra [May2022]

Cdn Institute HCI West

Cdn Institute HCI West

Talkdesk

Talkdesk

VG2022

VG2022

Contact Us

Canadian Healthcare Technology
1118 Centre Street, Suite 207
Thornhill, Ontario, Canada L4J 7R9
Tel: 905-709-2330
Fax: 905-709-2258
info2@canhealth.com

  • Quick Links
    • Current Print Issue
    • Print Archive
    • Events
    • Vendors
    • About Us
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Resources
    • White Papers
    • Writers’ Guidelines
    • Privacy Policy
  • Topics
    • Administrative Solutions
    • Clinical Solutions
    • Companies
    • Continuing Care
    • Diagnostics
    • Education & Training
  •  
    • Electronic Records
    • Government & Policy
    • Infrastructure
    • Innovation
    • People
    • Privacy and Security

© 2022 Canadian Healthcare Technology

The content of Canadian Healthcare Technology is subject to copyright. Reproduction in whole or in part without prior written permission is strictly prohibited. Send all requests for permission to Jerry Zeidenberg, Publisher.

Search Site

Error: Enter a search term

  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us